Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) ...Middle East

News by : (PR Newswire) -

– Broad label inclusive of all ages and disease severities – – Launch to be initiated in Germany – WARREN, N.J., June 24, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Sephience™ (sepiapterin) was granted marketing authorization by the European Commission...

Read More Details
Finally We wish PressBee provided you with enough information of ( Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU) )

Also on site :

Most Viewed News
جديد الاخبار